Recent findings indicate that 7nAChR activation may cause pathological angiogenesis in diabetic retinopathy by boosting VEGF expression [310, 311]
Recalls & Warnings September 24, 2020 FTC Sends Refund Checks to Consumers of Deceptive Joint Pain Supplement On September 24, 2020, the FTC announced it is mailing 4,782 checks totaling more than $76,000 to consumers who bought Isoprex, a supplement marketed with deceptive claims that it could treat or cure joint pain, muscle pain, headaches, and arthritis
10.2147/DDDT.S82030 7 KeremiB.LohinaiZ.KomoraP.DuhajS.BorsiK.JobbaGy-OvariG.et al (2009)
Fan, Y., Zhao, L., Lai, Y., Lu, K
Demine, S., Renard, P
National Law Review (Polsinelli PC) was explicit on April 22, 2026: removing a Category 2 bulk drug substance does not, on its own, authorize use of that substance in compounding or bring it within FDAs interim enforcement discretion policy for substances in Category 1. Even Category 1 substances are only under enforcement discretion, which is short of full authorization